Multidrug and extensively drug-resistant TB (M/XDR-TB): problems and solutions.

  title={Multidrug and extensively drug-resistant TB (M/XDR-TB): problems and solutions.},
  author={Rajendra Prasad},
  journal={The Indian journal of tuberculosis},
  volume={57 4},
Multi Drug Resistant Tuberculosis (MDR-TB) and Extensively Drug Resistant Tuberculosis (XDR-TB) are posing a threat to the control of tuberculosis. The first WHO-IUATLD antituberculosis drug resistance surveillance carried out in 1994 in 35 countries reported the median prevalence of primary and acquired multi drug resistance as 1.4% and 13% respectively. Subsequently, second, third and fourth WHO-IUATLD global drug resistance surveillances were carried out in 1996-99, 1999-2002 and 2002-2007… CONTINUE READING
25 Citations
13 References
Similar Papers


Publications citing this paper.
Showing 1-10 of 25 extracted citations


Publications referenced by this paper.
Showing 1-10 of 13 references

Collection of data Data shown in this report were officially reported to WHO through

  • South Africa, Tajikistan, Ukraine, Uzbekistan, Viet Nam
  • 2010

1912–2009), whose pioneering work in the use of combination drug therapy for the treatment

  • Sir John Crofton
  • 2009

Sir John Crofton, 1912–2009

  • C. Holme
  • International Journal of Tuberculosis and Lung…
  • 2009

Trends in MDR-TB levels as a reflection of TB control activities in three Russian regions. Abstract at the 5th Congress of the International Union Against Tuberculosis and Lung Disease, Europe Region

  • I Son
  • 2009

Cost-effectiveness of treating multidrug-resistant tuberculosis

  • SC Resch
  • PLoS Med,
  • 2006

Data analysis using regression and multilevel/hierarchical models

  • A Gelman, J. Hill
  • Geneva, World Health Organization,
  • 2006

Similar Papers

Loading similar papers…